An MSME supplier pursuing a delayed-payment reference under Section 18 of the MSMED Act can be stopped mid-stride by a single development on the buyer’s side: admission into the corporate insolvency resolution process under the Insolvency and Bankruptcy Code. From that moment, two special statutes — each with its own overriding clause — occupy the field, and the IBC’s collective process takes precedence over individual recovery. What the supplier does in the weeks after admission often determines whether anything is recovered at all.
The collision, in one view
| Stage of your MSEFC matter | Effect of buyer’s CIRP admission |
|---|---|
| Reference filed, conciliation pending | Proceedings against the buyer pause under the moratorium; file the claim with the IRP |
| Section 18(3) arbitration underway | Arbitration against the buyer cannot continue during moratorium; claim goes into the CIRP |
| Award passed, execution pending | Execution is barred during moratorium; the award supports the claim filed in CIRP |
| Buyer’s Section 34 challenge with pre-deposit made | Proceedings by the debtor stand on a different footing; take advice on the deposit’s status before any step |
Why the moratorium reaches the Facilitation Council
Section 14 of the IBC is drafted in deliberately wide terms: on admission, the adjudicating authority prohibits “the institution of suits or continuation of pending suits or proceedings against the corporate debtor including execution of any judgment, decree or order in any court of law, tribunal, arbitration panel or other authority.” A Facilitation Council reference seeks a money recovery from the buyer; the arbitration it ripens into under Section 18(3) is precisely a proceeding before an arbitration panel. The words leave no serious room for an MSME-shaped exception, and Section 238 of the IBC — “notwithstanding anything inconsistent therewith contained in any other law” — settles the order of precedence between the two special statutes.
The supplier’s working checklist
Watch for the public announcement. Admission into CIRP is followed by a public announcement inviting claims. Monitor the NCLT cause lists and the IBBI announcements if the buyer’s payment behaviour or market reports suggest insolvency is near.
File as an operational creditor, in time. Submit the claim in the prescribed form to the interim resolution professional with invoices, purchase orders, proof of delivery or service, the buyer’s acknowledgments, Udyam registration, and the MSMED interest computation. Late claims create avoidable controversy; extinguishment after plan approval is unforgiving.
Quantify interest correctly. The MSMED Act’s compound interest at three times the bank rate is part of the claim’s quantification. State principal and statutory interest separately, with the computation sheet.
Keep the MSEFC record alive. Inform the Council of the moratorium and seek adjournment sine die rather than withdrawal, so the reference can revive if the moratorium lifts without a plan — for instance, on liquidation of the CIRP being set aside, or against any party not protected by it.
Check for guarantees and co-obligors. The moratorium protects the corporate debtor alone. Director or promoter personal guarantees, and liabilities of entities outside the CIRP, can be pursued on their own terms.
After the CIRP: three endings
Planning before the storm
For suppliers with concentrated exposure to a single buyer, the best protection is contractual and operational: shorter credit cycles within the statutory forty-five days, personal or bank guarantees where bargaining power allows, invoice discounting through TReDS to move receivables off the books, and prompt invocation of the Samadhaan mechanism at the first sustained default rather than after months of accumulation. The MSMED Act gives a supplier speed; insolvency rewards those who used it early. Once CIRP intervenes, the remedy changes shape — from adjudication to participation — and the supplier’s diligence in the claims process becomes the measure of recovery.
Frequently Asked Questions
Does the moratorium stop MSEFC proceedings?
Yes, as against the corporate debtor. Section 14 of the IBC suspends the institution and continuation of suits and proceedings against the corporate debtor — the statutory text extends to proceedings before any court of law, tribunal, arbitration panel or other authority. A Section 18 reference, and the arbitration stage it leads to, are proceedings for recovery of a claim against the debtor and stand paused for the duration of the CIRP.
Which law prevails — MSMED Act or IBC?
Both statutes contain non-obstante provisions, but the IBC is the later special enactment and Section 238 gives it overriding effect. During CIRP, the collective resolution mechanism displaces individual recovery remedies, the MSEFC route included. The MSMED Act's interest entitlement remains relevant to quantifying the claim, but realisation happens through the insolvency process.
How should the supplier protect the claim during CIRP?
By filing it in the insolvency process itself. A supplier of goods or services is an operational creditor and should lodge its claim with the interim resolution professional in the prescribed form, within the timeline in the public announcement, supported by invoices, purchase orders, delivery proof and the statutory interest computation. An MSEFC award already in hand should be filed as the basis of the claim; a pending reference should be disclosed as a claim under adjudication.
What happens after the CIRP concludes?
If a resolution plan is approved, the supplier receives what the plan provides for operational creditors, and claims not provided for stand extinguished against the revived company. If the buyer goes into liquidation, the claim is lodged with the liquidator and paid per the statutory waterfall. Personal guarantees of promoters, where taken, are not shielded by the corporate moratorium and can still be pursued separately.